Therefore, further identifying the genetic abnormalities of C-MYC, BCL-2, and BCL-6 in DLBCL is of great significance to guide clinical diagnosis and treatment of DLBCL. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.